Drawing for BUG PHARMA

USPTO serial 78153337

BUG PHARMA

Reviewed by CopyMark Law Group

Reg. 2932682Status 710
Filing date
Status date
Registration date
Mar 15, 2005
Examiner
SMITH, REBECCA A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BUG PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian H. Batzli

BRIAN H BATZLI MERCHANT & GOULD, PCP O BOX 2910MINNEAPOLIS, MN 55402-0910UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and chemical substances containing arthropodic substances for use in manufacturing pharmaceutical preparations these being utilized in scientific industriesSECTION 8 - CANCELLED—
005PHARMACEUTICAL PREPARATIONS CONTAINING ARTHROPODIC DERIVED SUBSTANCES FOR THE TREATMENT OF HUMAN AILMENTS, MEDICAL DISORDERS AND DISEASES, NAMELY-- INFECTIOUS DISEASES CAUSED BY BACTERIA, FUNGI, VIRUSES, HELMINTHS, PROTOZOA AND PARASITES, INCLUDING AIDS AND HEPATITIS C; CANCER INCLUDING CANCERS OF THE BREAST, PROSTATE, LUNG, COLON, SKIN, BRAIN, BLOOD AND ERYTHROPOIETIC CELLS (LEUKEMIAS, MYELOMAS); HEART DISEASE; CARDIOVASCULAR DISEASE INCLUDING STROKE, HYPERTENSION AND ATHEROSCLEROSIS; NEUROSES AND PSYCHOSES - ANXIETY, SCHIZOPHRENIA, DEPRESSION, AND BIPOLAR DISORDER; OBESITY; DIABETES (TYPE 1 AND TYPE 2); ASTHMA; HYPERTENSION; HYPERCHOLESTEROLEMIA; PAIN (CHRONIC AND ACUTE); INFLAMMATION INCLUDING ARTHRITIS, OSTEOARTHRITIS; AUTOIMMUNE DISEASES; PSORIASIS, ECZEMA; CYSTIC FIBROSIS; GASTRO-INTESTINAL DISEASE, INCLUDING ULCERS, HELICOBACTER PYLORI INFECTIONS; SEXUAL DYSFUNCTION; OPHTHALMIC DISORDERS INCLUDING GLAUCOMA; IMMUNE SUPPRESSION FOLLOWING TRANSPLANTATION; REPRODUCTIVE DISORDERS; CONTRACEPTION AND CONTROL OF REPRODUCTION; CYSTIC FIBROSIS AND GENETIC DISORDERS; AND DEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DEMENTIASECTION 8 - CANCELLED—
042Pharmaceutical drug development services for drugs containing arthropodic derived substancesSECTION 8 - CANCELLED—
044PHARMACEUTICAL CONSULTATION NAMELY IN THE FIELD OF DRUGS CONTAINING ARTHROPODIC DERIVED SUBSTANCESSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2011C8..CANCELLED SEC. 8 (6-YR)—
Mar 15, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 2, 2004DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Nov 15, 2004IUCNNOTICE OF ALLOWANCE CANCELLED—
Nov 15, 2004MAILPAPER RECEIVED—
Oct 19, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 27, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 7, 2004NPUBNOTICE OF PUBLICATION—
Apr 26, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 5, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 5, 2004MAILPAPER RECEIVED—
Nov 19, 2003GNSLLETTER OF SUSPENSION E-MAILED—
Oct 11, 2003CFITCASE FILE IN TICRS—
Sep 24, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance